These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 15063935
1. [Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression]. Ntayi C, Hornebeck W, Bernard P. Pathol Biol (Paris); 2004 Apr; 52(3):154-9. PubMed ID: 15063935 [Abstract] [Full Text] [Related]
3. Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Shellman YG, Makela M, Norris DA. Melanoma Res; 2006 Jun; 16(3):207-11. PubMed ID: 16718267 [Abstract] [Full Text] [Related]
5. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis]. Masson V. Bull Mem Acad R Med Belg; 2006 Jun; 161(5):320-6. PubMed ID: 17283905 [Abstract] [Full Text] [Related]
12. Extracellular matrix remodelling: the role of matrix metalloproteinases. Stamenkovic I. J Pathol; 2003 Jul 15; 200(4):448-64. PubMed ID: 12845612 [Abstract] [Full Text] [Related]
13. [Type IV collagenases (MMP-2 and MMP-9) and their substrates--intracellular proteins, hormones, cytokines, chemokines and their receptors]. Hrabec E, Naduk J, Strek M, Hrabec Z. Postepy Biochem; 2007 Jul 15; 53(1):37-45. PubMed ID: 17718386 [Abstract] [Full Text] [Related]
14. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process. Amano S, Ogura Y, Akutsu N, Matsunaga Y, Kadoya K, Adachi E, Nishiyama T. Br J Dermatol; 2005 Dec 15; 153 Suppl 2():37-46. PubMed ID: 16280020 [Abstract] [Full Text] [Related]
15. Pericellular proteases in angiogenesis and vasculogenesis. van Hinsbergh VW, Engelse MA, Quax PH. Arterioscler Thromb Vasc Biol; 2006 Apr 15; 26(4):716-28. PubMed ID: 16469948 [Abstract] [Full Text] [Related]
16. The other side of MMPs: protective roles in tumor progression. Martin MD, Matrisian LM. Cancer Metastasis Rev; 2007 Dec 15; 26(3-4):717-24. PubMed ID: 17717634 [Abstract] [Full Text] [Related]
17. New functions of stromal proteases and their inhibitors in tumor progression. Noel A, Albert V, Bajou K, Bisson C, Devy L, Frankenne F, Maquoi E, Masson V, Sounni NE, Foidart JM. Surg Oncol Clin N Am; 2001 Apr 15; 10(2):417-32, x-xi. PubMed ID: 11382595 [Abstract] [Full Text] [Related]
18. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Augé N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, Krell HW, Salvayre R, Nègre-Salvayre A. Circulation; 2004 Aug 03; 110(5):571-8. PubMed ID: 15277330 [Abstract] [Full Text] [Related]
20. Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis. Qu XJ, Yuan YX, Tian ZG, Xu WF, Chen MH, Cui SX, Guo Q, Gai R, Makuuchi M, Nakata M, Tang W. Int J Mol Med; 2006 Oct 03; 18(4):609-14. PubMed ID: 16964412 [Abstract] [Full Text] [Related] Page: [Next] [New Search]